No Time to Wait: Single Session Intervention
No Time to Wait: A Randomized Control Trial of Online Single-Session Intervention for Children and Adolescents on Psychotherapy Waitlists in Hong Kong
1 other identifier
interventional
124
1 country
1
Brief Summary
Mental health problems in youth are prevalent, but early intervention effectively reduces symptoms, substance abuse risk, suicide, and comorbidities. In Hong Kong, however, only 26% of people with common mental disorders seek services (Lam et al., 2015), and even then, they face long delays-e.g., 90 weeks (90th percentile) for stable cases in public psychiatry clinics (Hospital Authority, 2024). Barriers include high costs, transportation issues, stigma, and preference for self-help, creating a strong need for scalable, accessible digital solutions, especially for youth. Single-Session Interventions (SSI) offer promise as brief, time-efficient tools that provide immediate support with minimal engagement burden. Online SSIs are often free, publicly available, and evidence-based. Research shows they reduce symptoms (moderate effect size Hedges' g = 0.32; 58% chance of better outcome vs. control), improve functioning, and boost satisfaction (Schleider \& Weisz, 2017). They work well for specific phobias and acute stress. Yet, their real-world acceptability, effectiveness outside trials, and integration with public services remain understudied-particularly for children/adolescents on waitlists. This pilot study evaluates an online single-session psychotherapy for youth (children/adolescents) on Hong Kong public psychotherapy waitlists, targeting depression and anxiety symptoms. It extends prior work by: Targeting two key constructs prominent in Asian contexts: Alexithymia - difficulty identifying/describing emotions; affects \~10% generally but 36% of Hong Kong adolescents (higher in females). It worsens depression, lowers well-being, complicates therapy, and reduces help-seeking. Fixed mindset (vs. growth mindset) - Asian groups show lower growth mindset levels; growth mindset buffers mental health issues (meta-analysis r = -0.220 with anxiety/depression/stress) and promotes better emotional regulation and treatment engagement. Examining how SSI influences acceptability and expectancy toward subsequent face-to-face psychotherapy. Hypotheses: SSI will reduce depression/anxiety symptoms more than treatment-as-usual. SSI will increase acceptability and positive expectancy for future in-person treatment. Change mechanisms-perceived behavioral control and emotional control-will mediate and sustain post-intervention outcomes. Overall, the study aims to test SSI as a bridge intervention to bridge service gaps, address culturally relevant barriers, and inform scalable mental health strategies in resource-constrained settings like Hong Kong's public system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2026
CompletedFirst Submitted
Initial submission to the registry
January 26, 2026
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
February 3, 2026
January 1, 2026
11 months
January 26, 2026
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
PHQ-9
From enrolment to 1 month after the end of treatment
GAD-7
From enrolment to 1 month after the end of treatment
TAS- 20-C
Alexithymia will be measured using the Toronto Alexithymia Scale (TAS-20), a validated self-report questionnaire assessing difficulty in identifying and describing feelings. The TAS- 20-C is a 20-item self-report scale rated on a five-point Likert scale. It includes three subscales: Difficulty Identifying Feelings (DIF) with items like "When I am upset I don't know if I am sad, frightened, or angry"; Difficulty Describing Feelings (DDF) with statements such as "I find it hard to describe how I feel about people"; and Externally Oriented Thinking (EOT), exemplified by "I prefer to just let things happen rather than to understand why they turned out that way." Scores can range from 20 to 100, where higher scores denote higher alexithymia. The TAS-20-C is validated for Chinese populations (Zhu et al., 2007). In this research, the scale achieved a Cronbach's alpha of 0.80.
From enrolment to 1 month after the end of treatment
Secondary Outcomes (3)
Perceived primary (behavioral) control
From Enrolment to 1 month after the end of treatment
Perceived secondary (emotional) control
From enrolment to 1 month after the end of treatment
Attitudes Toward Seeking Professional Psychological Help (ATSPPH) Short Form
From enrolment to 1-month after the end of treatment
Study Arms (2)
Intervention Group
EXPERIMENTALParticipants who receive online single session intervention
Control Group
NO INTERVENTIONWaitlist Control
Interventions
Participants would receive an online single session intervention, which includes animation and exercises that enhance children and adolescents' growth mindset
Eligibility Criteria
You may qualify if:
- (1) being Hong Kong residents aged 12 - 17; (2) having anxiety and/or depression symptoms, scoring 10 or above, in accordance with Patient Health Questionnaire (PHQ-9) or General Anxiety Disorder-7 (GAD-7); (3) having access to the internet and a valid email address for communication, (4) being able to understand and read Chinese and, (5) participants' parent or legal guardian will be willing to give informed consent.
You may not qualify if:
- (1) they have received another psychological treatment for depression and/or anxiety in the past 3 months, (2) they report a diagnosis of other comorbid severe psychiatric disorder, including psychotic disorder, bipolar disorder, dissociative disorder, or other neurocognitive disorders that make participation infeasible or interfere with the adherence to the digital self-help intervention, (3) they would participate in another similar study concurrently, (4) any suicidal ideation is reported (score \> 2 on Question 9 of the Beck Depression Inventory), (5) they report substance abuse history, (6) having changes in psychotropic medication within 2 weeks before baseline assessment; or (7) they report pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- United Christian Hospitallead
- Hong Kong Universitycollaborator
Study Sites (1)
United Christian Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Psychologist
Study Record Dates
First Submitted
January 26, 2026
First Posted
February 3, 2026
Study Start
January 10, 2026
Primary Completion (Estimated)
December 12, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
February 3, 2026
Record last verified: 2026-01